Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+ : Original Research : anti-cyclic citrullinated peptide
In: Rheumatology and Therapy, Jg. 10 (2023-06-01), Heft 3, S. 575-587
academicJournal
Zugriff:
Titel: |
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+ : Original Research : anti-cyclic citrullinated peptide
|
---|---|
Autor/in / Beteiligte Person: | Harrold, Leslie R. ; Wittstock, Keith ; Kelly, Sheila ; Han, Xue ; Shan, Ying ; Guo, Lin ; Moore, Page C. ; Khaychuk, Vadim |
Zeitschrift: | Rheumatology and Therapy, Jg. 10 (2023-06-01), Heft 3, S. 575-587 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
DOI: | 10.1007/s40744-022-00523-z |
Sonstiges: |
|